u 69593 has been researched along with 3-(2-((cyclobutylmethyl)(phenethyl)amino)ethyl)phenol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Berzetei-Gurske, IP; Guerrieri, E; Schmidhammer, H; Spetea, M | 1 |
| Barlow, D; Benyhe, S; Chou, K; Della Valle, A; Houseknecht, K; Marinaccio, L; Masci, D; Minosi, P; Mollica, A; Pieretti, S; Scioli, G; Stefanucci, A; Streicher, JM; Szucs, E; Tanguturi, P | 1 |
| Guerrieri, E; Mallareddy, JR; Schmidhammer, H; Spetea, M; Tóth, G | 1 |
3 other study(ies) available for u 69593 and 3-(2-((cyclobutylmethyl)(phenethyl)amino)ethyl)phenol
| Article | Year |
|---|---|
Discovery and pharmacological evaluation of a diphenethylamine derivative (HS665), a highly potent and selective κ opioid receptor agonist.
Topics: Acetic Acid; Analgesics; Animals; Drug Discovery; Mice; Nociception; Pain; Phenethylamines; Receptors, Opioid, kappa | 2012 |
Discovery of κ Opioid Receptor (KOR)-Selective d-Tetrapeptides with Improved
Topics: | 2022 |
Synthesis and pharmacological evaluation of [(3)H]HS665, a novel, highly selective radioligand for the kappa opioid receptor.
Topics: Analgesics; Analgesics, Opioid; Animals; Benzeneacetamides; Brain; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Guinea Pigs; Humans; Naloxone; Phenethylamines; Protein Binding; Pyrrolidines; Radioligand Assay; Receptors, Opioid, kappa; Time Factors; Transfection; Tritium | 2015 |